Semler Scientific (NASDAQ:SMLR) Announces Bitcoin Holdings and ATM Activity Updates

Semler Scientific, Inc., a company focused on developing and marketing technology products and services to healthcare providers, recently disclosed important updates regarding its bitcoin holdings and activity with respect to its at-the-market equity offering programs. The company’s latest press release, issued on January 13, 2025, sheds light on its Bitcoin (BTC) holdings, capital market activities, and BTC Yield, a key performance indicator.

Bitcoin Update

Semler Scientific disclosed that between December 16, 2024, and January 10, 2025, it acquired 237 bitcoins for $23.3 million. The company funded these acquisitions using proceeds from its at-the-market (ATM) offering and operational cash flow, at an average price of $98,267 per bitcoin. As of January 10, 2025, Semler Scientific held a total of 2,321 bitcoins, purchased for an aggregate of $191.9 million at an average price of $82,687 per bitcoin.

ATM Update

Additionally, Semler Scientific highlighted updates regarding its Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. Through the ATM offering, Semler Scientific filed a second prospectus supplement on December 16, 2024, raising an additional $50.0 million for an overall total offered under the ATM of $150.0 million. The company reported generating approximately $121.8 million of gross proceeds from sales via the ATM offering as of January 10, 2025.

BTC Yield as a Key Performance Indicator (KPI)

Semler Scientific also provided insights into its BTC Yield performance indicator. From October 1, 2024, to January 10, 2025, the company reported a BTC Yield of 72.6%. Moreover, from July 1, 2024, to January 10, 2025, the BTC Yield stood at 99.3%. Semler Scientific utilizes BTC Yield as a KPI to evaluate its strategy of acquiring Bitcoin in a manner believed to be accretive to stockholders.

Importance of BTC Yield KPI

It’s essential to note that BTC Yield is a metric that evaluates the percentage change period-to-period of the ratio between Semler Scientific’s Bitcoin holdings and its Assumed Diluted Shares Outstanding. The company uses this KPI to gauge the effectiveness of issuing additional shares of common stock to fund Bitcoin acquisitions, providing insights into its strategic decisions regarding the use of equity capital.

Forward-Looking Statements

As with all forward-looking statements, this update from Semler Scientific carries inherent risks and uncertainties, as detailed in the company’s filings with the Securities and Exchange Commission. The actual results may vary from the projections in this report due to various factors affecting the company’s operations and the Bitcoin market.

Semler Scientific’s recent disclosure emphasizes its commitment to transparency and strategic decision-making in managing its Bitcoin holdings and equity offerings.

This is not an offer or solicitation for securities but rather an informative update on Semler Scientific’s recent activities in the cryptocurrency space and capital markets. Investors are encouraged to rely on the company’s financial disclosures for authoritative information.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Semler Scientific’s 8K filing here.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.